Advertisement

Topics

Latest "Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report" News Stories

07:50 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report" found in our extensive news archives from over 250 global news sources.

More Information about Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report for you to read. Along with our medical data and news we also list Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report Companies for you to search.

Showing "Novavax NVAX Pharmaceuticals Healthcare Deals Alliances Profile Report" News Articles 1–25 of 36,000+

Thursday 21st March 2019

Can we import improvements from industry to healthcare?

Exhortations to learn from other industries have been common in the world of healthcare improvement since the inception of the discipline.1 These are not always helpful. Recounting oversimplified...


ASIT biotech (ASIT) - Supportive data on ASIT’s short-course therapy

Edison Investment Research - Pharmaceuticals & healthcare - ASIT biotech: ASIT has announced the publication of mode of action data from its first Phase III study for its gp-ASIT+ product for grass pollen allergies. This is supportive of ASIT’s short-course adjuvant-free approach to allergy vaccination. The study demonstrated both immunological and symptomatic responses that persisted until ...

Novocure’s Chief Science Officer Retires after 17 Years of Service

Novocure (NASDAQ: NVCR) today announced the retirement of Dr. Eilon Kirson, Novocure’s Chief Science Officer and Head of Research and Development, effective May 1, 2019. Dr. Kirson will step away from the healthcare industry and frequent international travel to spend more time with his family. “While this was a difficult decision, it is the ri...


Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye, today announced the commencement of patient dosing in its Phase 2 clinical tri...

PredictImmune Win Business Weekly Life Science Innovation (Product) Award

Developers of pioneering prognostic tools recognised for its innovative product development and contribution to life science discovery PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, are delighted to have been awarded the Life Science Innovation award for...

Rare Diseases: PKU GOLIKE® Debuts in Germany

PKU GOLIKE®, the brand new generation of Phenylalanine (PHe)-free medical food for Phenylketonuria (PKU) dietary management, is now available in Germany and Austria, promoted and distributed directly by APR Applied Pharma Research s.a. (APR) through its local subsidiary, APR Deutschland. The company has taken advantage of the 33th Annual Meeting ...

Tool Pouches Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Tool Pouches report provides an independent information about the Tool Pouches industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The report woul...

NHS needs £900m a year to avoid crippling staff shortages

Report predicts nurse shortage will triple to over 100,000 within the next 10 years

Innovus Pharmaceuticals Reports Preliminary Annual 2018 Net Revenue of $24 Million

Preliminary Annual Revenue Increase by 2.7x Compared to Prior Year Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV) today announced preliminary annual 2018 net revenue is estimated to be $24.0 million or approximately 2.7x the annual 2017 net revenue of $8.8 million. Innovus Pharma’s annual 2018 anticipated n...

AGH Study Advances Tool Used in Determining Treatment for Patients with Pulmonary Arterial Hypertension

Based on results of a research conducted at Allegheny General Hospital, the REVEAL 2.0 risk score calculator is expected to become the most commonly used risk prognostic tool for patients suffering from pulmonary arterial hypertension. PITTSBURGH, Pa. (PRWEB) March 21, 2019 A study conducted by researchers at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN), has demonstrat...

Modra Pharmaceuticals Announces First Patients Treated in Phase IIa Metastatic Breast Cancer Trial

--Study will test efficacy and safety of novel docetaxel-based oral therapeutic-- Modra Pharmaceuticals B.V. (“Modra”) today announced that the first patients have been treated in its Phase IIa study in patients with recurrent or metastatic HER-2 negative breast cancer. The trial will evaluate the efficacy and safety of Modra’s lead product, Modr...

Hologic Opens State-Of-The-Art Learning and Experience Centre In Zaventem, Belgium

Women’s health company offers new training facility for partners, healthcare professionals and employees Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company focused on improving women’s health and well-being through early detection and treatment, today opened its first Learning and Experience Centre in Zaventem, Belgium (a munici...

Orexo Publishes the Annual Report for 2018

UPPSALA, Sweden, March 21, 2019 /PRNewswire/ -- Orexo's Annual Report, including the Sustainability Report, for the 2018 fiscal year has been published and can be downloaded on the company's websi...

Marinomed Biotech AG (MARI-AT): Solving the insoluble

goetzpartners securities Limited 21-March-2019 / 08:15 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail cli...

Bavarian Nordic Announces Annual Report 2018

COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Below is a summary of business progress, financial performance for the year and financial outlook for 2019 from the report. The full report is attached as a PDF file and can be found on the company's website, www.bavarian-nordic.com.  Delivering on ...

Pasteurized Cream Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Pasteurized Cream report provides an independent information about the Pasteurized Cream industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The r...

Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody

SUZHOU, China, March 21, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient has been successfully dosed in a Phase IIa clinical study of IBI306, a recombinant fully human anti-proprotein convertase substilisin/kexin type 9 (anti-PCSK...

The Zur Rose Group accelerates growth

EQS Group-News: Zur Rose Group AG / Key word(s): Annual Results 21.03.2019 / 07:00 Press release 2018 operating result The Zur Rose Group accelerates growth - Revenue and earnings targets met - Significant expansion of market leadership in Europe and acceleration of internationalisation - Focus 2019 to 2021: Integration of the new companies and leveraging the opportunities of digita...

UVCured Coatings Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe UVCured Coatings report provides an independent information about the UVCured Coatings industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The rep...

A New York union accused AbbVie and seven other drug makers of anticompetitive behavior for deals that delayed the availability of lower-cost biosimilar versions of their expensive drugs. https://buff.ly/2JqufA1 

A New York union accused AbbVie and seven other drug makers of anticompetitive behavior for deals that delayed the availability of lower-cost biosimilar versions of their expensive drugs. https://buff.ly/2JqufA1 

Wednesday 20th March 2019

European Parliament's report calls on EU to develop policies to regulate endocrine-disrupting chemicals

The Endocrine Society applauded the European Parliament's release of a report demonstrating that endocrine-disrupting chemicals pose a serious threat to the health of current and future generations and illustrating the need for additional action by policymakers in the EU to address this issue.

AmCham EU CEO emphasizes opportunities US business bring to Europe

Interview with Susan Danger, CEO of the American Chamber of Commerce to the EU (AmChamEU).1. The theme of your transatlantic conference this year was ‘Atlantic drift? The EU, the US and the WTO in a new world.’ What was your main takeaway from the conference? Are we drifting?The EU and the US are historic partners and allies and our relationship is here to stay. Having said that, there are a f...

CORRECTING and REPLACING Trust, Value, Credibility – A Guided Approach to Thought Leadership from PAN Communications

New eBook connects programs to increased share of voice and brand awareness Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TRUST, VALUE, CREDIBILITY – A GUIDED APPROACH TO THOUGHT LEADERSHIP FROM PAN COMMUNICATIONS New eBook connects prog...

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

Corza Health Emerges Led by Former NuVasive, GreatCall Executives

A Chicago-based private equity firm has tapped the former head of NuVasive and finance chief of GreatCall to start a new healthcare company in San Diego. The company, Corza Health, is headed by Greg Lucier, most recently CEO at NuVasive, and backed by the PE firm, GTCR, with money from its $5.25 billion Fund XII. […]


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks